Revenue cycle has traditionally been about converting care into reimbursement. RMS and Finalytics are pushing the model one step further: turn eligible claims into liquidity before the payer actually pays. The result is a category that looks less like conventional RCM software and more like embedded finance built directly on top of the claim.
The basic workflow is simple.
Eligible claims are sent to Finalytics for evaluation. Finalytics determines the allowable value and provides accelerated payment within three days. The claim then continues through the payer's normal adjudication process. RMS receives remittance information and helps reconcile the eventual payment and remaining balances.
The provider ultimately receives the full amount paid by the payer, according to the companies.
The operational claim still takes however long it takes to adjudicate.
But the provider's access to cash no longer has to move on the same clock.
Revenue cycle is beginning to separate two things that have historically been treated as the same problem: how long a payer takes to pay and how long a provider has to wait for liquidity.
Most revenue-cycle technology improves cash flow indirectly.
Eligibility tools prevent avoidable denials. Coding tools improve claim accuracy. Denial automation speeds recovery. Patient-financial tools accelerate self-pay collections. Workflow automation lowers cost to collect.
Claims monetization attacks the timing problem directly.
The technology does not need the payer to move faster before the provider can access cash.
Instead, a financing layer sits on top of the claim and advances liquidity against expected reimbursement.
That makes the claim both a reimbursement transaction and a financeable asset.
The announcement comes as provider economics remain under pressure.
RMS cites American Hospital Association data showing total hospital expenses grew 7.5% in 2025, more than twice the growth rate of hospital prices.
At the same time, payer collection cycles remain long and uneven.
A health system can therefore have strong volume, recognized revenue, and millions of dollars of insurance receivables while still facing pressure on available cash.
That is not necessarily a revenue problem.
It is a timing problem.
Claims monetization is designed to close that gap.
Finalytics markets its platform around a clear promise: eligible claims paid in three days.
The company also says its model can reduce outstanding accounts receivable by as much as 90%.
Those are company-reported marketing claims and should be evaluated in the context of each provider's payer mix, eligibility criteria, pricing, and operating model.
But the concept creates an important distinction.
A provider's operational days in A/R might still be 45 or 60 days.
Its economic access to a portion of that cash could be three days.
That makes traditional DSO a less complete measure of liquidity on its own.
If a provider can access cash against receivables before the payer settles them, the age of the claim and the age of the provider's cash are no longer the same thing.
Revenue-cycle leaders traditionally optimize clean-claim rate, denial rate, days in A/R, net collection rate, cost to collect, and cash collections.
Claims monetization introduces another variable:
cost of capital.
Imagine a health system with $100 million of insurance receivables.
The question is no longer simply, “How quickly can the RCM team collect this?”
It becomes, “Which claims should we monetize now, which should we hold, and what is the economic value of accelerating each dollar?”
That is a treasury-management decision informed by revenue-cycle data.
Not every claim has the same financial characteristics.
A clean commercial claim to a payer that reliably pays in 18 days is a very different asset from a complex claim to a payer with a 60-day cycle, high denial frequency, or frequent reimbursement variance.
Finalytics says RMS's remittance infrastructure allows its platform to extract data used to value and risk-adjust financed claims. Its materials also emphasize weighted insurance-outstanding metrics and payer payment behavior.
That creates an obvious long-term opportunity.
A claims-financing platform could price liquidity using:
The same data used to operate the revenue cycle becomes an underwriting engine.
There is one important point the headline does not answer.
Accelerated payment is not the same as free capital.
The companies emphasize that the provider ultimately receives 100% of what the payer pays, and Finalytics says its pricing is designed for providers of different sizes. But public pricing materials do not disclose a simple universal financing rate or effective cost for monetizing claims.
That means the CFO calculation still matters.
The value of accelerating a dollar of reimbursement should be compared with alternative sources of liquidity, including revolving credit facilities, cash reserves, better collections performance, or simply allowing a predictable claim to mature normally.
Claims monetization can be strategically valuable without automatically being the cheapest capital available.
There is also an operational second-order effect.
Traditional A/R work queues prioritize accounts based on balance, age, payer, denial status, and recoverability.
But once a claim has already generated accelerated liquidity, the urgency associated with that account changes.
The provider has already accessed much of the cash.
That could allow revenue-cycle teams to focus human attention on accounts where ultimate recovery is at risk rather than accounts where cash is simply delayed.
The financing layer therefore has the potential to change not only the balance sheet but also the work queue.
RMS and Finalytics have been working together for years. Finalytics says the companies have partnered for more than seven years on cash-flow improvement, remittance automation, payer behavior analysis, and revenue-cycle modernization.
That makes this announcement more interesting, not less.
The underlying concept has had time to mature.
What is changing is the market context around it.
Provider margin pressure, rising A/R days, increasingly sophisticated payer intelligence, better remittance data, and more automated revenue-cycle workflows make claims monetization more strategically relevant than it may have been when the partnership began.
Finalytics' sister platform Denalytics applies the same idea to dental insurance through Denaflex.
The company markets three-day dental claim payments, centralized remittance automation, and reduced insurance A/R for DSOs and dental practices.
That matters because dental groups often have many locations, fragmented payer mixes, and meaningful working capital trapped in insurance receivables.
The financial infrastructure opportunity is not limited to hospitals.
Healthcare providers carry enormous receivable balances.
Those receivables contain unusually rich information about who owes the money, what contract governs payment, what historically gets paid, how long it takes, and how likely the expected amount is to change.
Historically, RCM used that information mostly to chase the payment.
Modern data infrastructure can use it to value the payment.
That creates a new category:
revenue-cycle liquidity infrastructure.
The most valuable platform may eventually combine claims intelligence, payer intelligence, reimbursement prediction, remittance automation, and working capital in the same system.
The interesting part of RMS + Finalytics is not simply that an eligible claim can generate cash in three days.
It is the conceptual shift underneath it.
The revenue cycle has historically been an operational system designed to convert clinical activity into reimbursement.
It is increasingly becoming a financial system capable of predicting, valuing, and monetizing reimbursement before the payer sends the money.
That introduces a new group of competitors into the RCM landscape:
fintech platforms, lenders, payment networks, capital providers, and software companies capable of underwriting healthcare receivables.
The next RCM platform may not just help providers collect cash faster. It may help them decide when future reimbursement should become cash today.
Deal signals, payer shifts, and AI developments — before they reshape your revenue cycle. Free, every week.
Sources: RMS / Finalytics announcement via Business Wire · Finalytics product materials · RevCycleAI analysis · October 5, 2026